For high-grade SCC of the palate, adjuvant radiation is often used after surgical resection for positive or close margins, cervical metastasis, perineural invasion, and recurrent disease.

For AdCC, adjuvant chemoradiation is recommended after surgical resection for tumors with close proximity to the skull base, cervical metastasis, perineural invasion, solid-variant histology, and recurrent tumors.

Radiation therapy for MEC is recommended for patients with cervical lymph node metastasis, bony involvement, recurrent disease, positive margins on surgical resection, perineural invasion, lymphovascular invasion, and anaplasia.

Radiation therapy for PLGA has been suggested for cases of positive margins, perineural invasion, and lymph node metastasis.

Unresectable LGPA lesions are treated with radiation therapy with reports showing successful tumor shrinkage when doses of 4000 to 5000 rads are used.

Radiation has not been found to be effective for acinic cell carcinoma.

Radiation therapy has been utilized in mucosal melanoma with one report recommending 25 Gy over 25 fractions.

NHL is treated with a combination of radiation and chemotherapy. Radiation has been reported to be given at a range of 24-45 Gy over 16-25 fractions.